FREE Online CE - RISHP Lunch and Learn: Cardiovascular and Renal Outcomes for Type 2 Diabetes Medications

Rhode Island Society of Health System Pharmacists 

FREE Online CE - Cardiovascular and Renal Outcomes for Type 2 Diabetes Medications

Pharmacists 

Today March 4th 2020

12:00pm to 1:00pm

Online &
Rhode Island Hospital

593 Eddy St Providence, RI 02903

Click Here To Register

Topics:

“Cardiovascular and Renal Outcomes for Type 2 Diabetes Medications"

1. Summarize current guideline recommendations regarding Glucagon-like Peptide 1 Receptor Agonists (GLP-1RA) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT-2i.

2. Describe clinical trials examining the cardiovascular and renal effects of GLP-1RAs and SGLT-2is.

3. Identify class differences and patient-specific factors that would guide treatment decisions when considering therapy with SGLT-2 inhibitors and/or GLP-1 agonists.

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists will receive 1.0 contact hour (0.1 ceus) for the educational activity. UAN: 0060-9999-20-019-L01-P for the live program on March 4, 2020. UAN: 0060-9999-20-019-H01-P for the home study.

REQUIREMENTS FOR CE CREDIT
A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.

Financial support provided by the Rhode Island Society of Health-System Pharmacists